GUANGZHOU, China, Nov. 24, 2010 /PRNewswire-Asia-FirstCall/ -- China Medicine Corporation (OTC Bulletin Board: CHME) (“China Medicine” or “the Company”), a leading manufacturer, developer and distributor of Western pharmaceuticals, traditional Chinese medicines, and other health products in the People’s Republic of China, today announced its participation in the CLSA Emerging Markets Pharma Conference, to be held December 1, 2010 at the Jumeirah Essex House in New York.
Management is scheduled to present at 2:15 pm ET on Wednesday, December 1, 2010, and meet with institutional investors throughout the day.
For further details, please contact your CLSA institutional sales representative.
About China Medicine Corporation
China Medicine Corporation, a vertically integrated enterprise with a research and development centre, manufacturing facility and well established sales network, engages in the production and distribution of prescription and over the counter drugs, traditional Chinese medicine products, herbs and dietary-supplements, medical devices, and medical formulations in China. The Company is developing a number of proprietary products for a variety of indications, including oncology, high blood pressure and toxin removal from food and animal feeds. For more information, please visit the Company’s website at http://www.cmc621.com.
Contact Information | |
ICR, Inc. | |
In New York: Ms. Christine Duan: 1-203-682-8200 | |
In Beijing: Ms. Wen Lei Zheng: 86-10-6599-7968 | |
China Medicine Corporation | |
In Guangzhou: Ms. Gavin Chen: 86-20-8737-2102 | |
SOURCE China Medicine Corporation
